EDIT Q1 2021 Earnings — Editas Medicine, Inc. Revenue & Financial Results | Market Cap Arena

EDITEditas Medicine, Inc.

$260M

Q1 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$6M+13.6% YoY

Gross Profit

-$35M-545.3% margin

Operating Income

-$57M-875.3% margin

Net Income

-$57M-872.9% margin

EPS (Diluted)

$-0.86

QoQ Revenue Growth

-43.1%

Cash Flow

Operating Cash Flow

-$49M

Free Cash Flow

-$50M

Stock-Based Comp.

$12M

Balance Sheet

Total Assets

$780M

Total Liabilities

$142M

Stockholders' Equity

$638M

Cash & Equivalents

$355M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$6M	$6M	+13.6%
Gross Profit	-$35M	-$29M	-22.8%
Operating Income	-$57M	-$47M	-22.0%
Net Income	-$57M	-$38M	-50.4%